February 20, 2017
A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) will review on March 3 whether to recommend approval for a batch of drugs including Takeda Pharmaceutical’s multiple myeloma (MM) drug ixazomib, sold as Ninlaro overseas. The...read more